Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($) 3 Months Ended 9 Months Ended
September 30, 2023 September 30, 2023 September 30, 2023 September 30, 2023
Operation Expension
Research and development $ 239,199 $ 745,461 $ 699,413 $ 1,191,901
General and administrative 3,707,311 1,208,319 11,319,465 2,448,091
Total operating expenses 3,946,510 1,953,780 12,018,878 3,639,992
Total operating expenses (3,946,510) (1,953,780) (12,018,878) (3,639,992)
Operation Expension
Research and development $ 239,199 $ 745,461 $ 699,413 $ 1,191,901
General and administrative 3,707,311 1,208,319 11,319,465 2,448,091
Total operating expenses 3,946,510 1,953,780 12,018,878 3,639,992
Total operating expenses (3,946,510) (1,953,780) (12,018,878) (3,639,992)
Operation Expension
Research and development $ 239,199 $ 745,461 $ 699,413 $ 1,191,901
General and administrative 3,707,311 1,208,319 11,319,465 2,448,091
Total operating expenses 3,946,510 1,953,780 12,018,878 3,639,992
Total operating expenses (3,946,510) (1,953,780) (12,018,878) (3,639,992)